Peter Kleinhenz is a Venture Partner with Fletcher Spaght Ventures and a Managing Director of CID Capital, Inc. He has been actively involved in technology-based businesses as an entrepreneur, consultant, and investor for over 28 years and in the life sciences sector for over 25 years.
He joined Fletcher Spaght Ventures in 2009 and represents them in Ohio. He serves as an observer and member of the audit committee for FSV’s investment in Surgiquest, Inc.
Peter is a director or observer for the following CID investments: Axiomed Spine Corporation, EKOS Corporation, Celleration, Inc., RedPath, Inc. and MedVantx, Inc. His also represented CID in: Renal Solutions, Inc. (sold to Fresenius, Inc.), QIS, Inc. (sold to Abeam Consulting), and Atlantis Components, Inc. (sold to Astra Tech, Inc.).
Prior to joining CID Capital in 2001, Peter served as Vice President of Commercialization-Life Sciences for Battelle Memorial Institute working in medical devices, pharmaceutical products and toxicology sectors and as a consultant to The Cleveland Clinic Foundation, Battelle, and a variety of life science start-ups, assisting in developing business plans and raising seed and venture capital. He was CEO of Progenics, Inc., which developed and manufactured medical products and industrial controls, which he sold to FITCH, Inc. in 1997. He was a member of the founding management team of Neoprobe Corporation a biotech and medical device company focused on cancer diagnostics and therapeutics. At Neoprobe he served in a variety of senior executive positions including CFO, Vice President of Manufacturing, and Vice President of Product and Market Planning. Prior to this he was an Investment Analyst with the Thomas Edison Program, Ohio Department of Development where he focused on pre seed and seed stage company financings.
Peter has been a member of the Board and Executive Committee of BioOhio since 1991. He is also a founding member and Board member of the MidAmerica Health Investment Network and is the founder and Chairman of the MHIN’s annual MidAmerica Healthcare Investment Forum.
Peter received an MBA from Case Western Reserve University, a bachelor’s degree from Loyola University of Chicago, and is a Certified Public Accountant licensed (inactive status) in Ohio.